Araştırma Makalesi

Use of integrative medicines by chronic obstructive pulmonary disease patients and its relation with hopelessness levels

Cilt: 45 Sayı: 4 27 Aralık 2020
Gamze Muz *, Ayser Erat , Şeydanur Şamdanlı , Nisa Yavuzer
PDF İndir
EN TR

Use of integrative medicines by chronic obstructive pulmonary disease patients and its relation with hopelessness levels

Abstract

Purpose: Increase in chronic diseases significantly increases the use of integrative medicines in symptom management. This study aims to determine the use of integrative medicines and the levels of hopelessness of individuals with chronic obstructive pulmonary disease (COPD). Material and Methods: This descriptive and cross-sectional study was conducted in a chest disease services with 259 COPD’s patients. Data were collected with the Questionnaire Form and Beck’s Hopelessness Scale. Results: Of the participants, the most common integrative medicine was herbal methods (66.2%). The hopelessness level of the group using integrative medicine was high, but the difference between the groups was not statistically significant. The participants received information about the use of integrative methods from TV, radio and magazine and used integrative methods in symptom management. Conclusion: The most common integrative medicine used was herbal methods. In addition, level of hopelessness did not affect integrative medicine’s usage. The results of such findings are to identify the causes of integrative medicine use and to ensure education for healthcare professionals.

Keywords

complemantary medicine , COPD , hope

Kaynakça

  1. References 1. GOLD. Global Initiative for Chronic Obstructive Lung Disease. “Global Strategy for the Diagnosis, Management and Prevention. A Guide for Health Care Professionals 2019 Report.” 2019.
  2. 2. Chronic obstructive pulmonary disease (COPD). https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd) (accessed 2020 Jul 27).
  3. 3. Chronic obstructive pulmonary disease 2019. https://www.toraks.org.tr/halk/Page.aspx?d=10 (accessed 2020 Apr 16).
  4. 4. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2020. www.goldcopd.org
  5. 5. Minakata Y, Morishita Y, Ichikawa T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Ichinose M. Effects of pharmacologic treatment based on airflow limitation and breathlessness on daily physical activity in patients with chronic obstructive pulmonary disease. Int J COPD. 2015;10:1275–1282.
  6. 6. Ding B, Small M, Bergström G, Holmgren U. COPD symptom burden: Impact on health care resource utilization, and work and activity impairment. Int J COPD. 2017;12:677–689.
  7. 7. Polat H, Erguney S. The effect of reflexology applied to patients with chronic obstructive pulmonary disease on dyspnea and fatigue. Rehabil Nurs. 2017;42:14–21.
  8. 8. Oncu E, Zincir H. The effect of transcutaneous electrical nerve stimulation in patients with acute exacerbation of chronic obstructive pulmonary disease: randomised controlled trial. J Clin Nurs. 2017;26:1834–1844.
  9. 9. Mularski RA, Munjas BA, Lorenz KA, Sun S, Robertson SJ, Schmelzer W, Kim AC, Shekelle PG. Randomized controlled trial of mindfulness-based therapy for dyspnea in chronic obstructive lung disease. J Altern Complement Med. 2009;15:1083–1090.
  10. 10. Kütmeç Yılmaz C, Duru Aşiret G, Çetinkaya F, Kapucu S. The use of complementary and alternative medicine of chronic obstructive pulmonary disease patients. DEUHFED. 2017;10:216–221.

Kaynak Göster

MLA
Muz, Gamze, vd. “Use of integrative medicines by chronic obstructive pulmonary disease patients and its relation with hopelessness levels”. Cukurova Medical Journal, c. 45, sy 4, Aralık 2020, ss. 1598-06, doi:10.17826/cumj.742875.